Postbiotics in Psychiatry: Can Microbial Metabolites Replace Live Microbial Therapies?
Abstract
Objective: : Live biotherapeutics—probiotics and synbiotics—have dominated microbiota-gut-brain axis interventions in psychiatry, yet clinical trials show modest, inconsistent effects, while mechanistic work increasingly attributes their benefits to microbial metabolic products rather than colonization. This review asks whether postbiotics—inanimate microorganisms and/or their components that confer a health benefit, per the International Scientific Association for Probiotics and Prebiotics—can replace live microbial therapies in psychiatry. Method. A narrative synthesis was conducted of peer-reviewed literature spanning microbiome science, neuropharmacology, and psychiatry, including consensus statements, systematic reviews, meta-analyses, mechanistic preclinical studies, and human trials of microbial-metabolite-based and live-microbial interventions in mood, psychotic, and neurodevelopmental disorders. Results. Short-chain fatty acids—particularly butyrate—exert antidepressant and anxiolytic effects in animal models via histone deacetylase inhibition, neurotrophic upregulation, and microglial regulation, while microbially derived gamma-aminobutyric acid, serotonin, and indole derivatives signal to the brain through vagal, endocrine, and immune routes. Human data remain limited but supportive: fecal short-chain fatty acid profiles track depressive symptoms, and sodium butyrate supplementation reduced anxiety and depression scores in a randomized ulcerative-colitis trial.…
How strong is the evidence?
Evidence Hub reads this as a randomized trial. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
- Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials
- Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta‐analysis, and network meta‐analysis of randomized trials with 94,283 participants
- Screen time increases overweight and obesity risk among adolescents: a systematic review and dose-response meta-analysis
- Exposure to WHO AWaRe antibiotics and isolation of multi-drug resistant bacteria: a systematic review and meta-analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.